Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2019

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Optimize your pharmaceutical portfolio strategy

Our pipeline data, historical metrics, deals and milestone information and forecasts arm you with the data you need to optimize your company's portfolio.

Drive commercial success

drive commerical success pharma intelligence

As a pharmaceutical company, you need to continually evaluate your disease strategy to discern gaps in your portfolio and decide whether to build or buy. Internal candidates need to be assessed against competitors’ pipelines, and assets suitable for expanding your portfolio identified. To do all this, the right data and analysis is essential.

How we can help

Our portfolio strategy solutions give you timely and accurate intelligence you can act on, including:

A wealth of expert insights gathered by our global team of more than 65 journalists and over 300 specialist analysts
The most up-to-date, comprehensive coverage of drugs, companies, epidemiology, diseases, strategy, and pricing and reimbursement trends
Sales forecasts for pipeline candidates and patient-based sales forecasts from surveys of more than 200 physicians per indication
Country-specific treatment algorithms and reimbursement scenarios
Comprehensive and timely market research reports to help you understand macro trends and synthesize key insights so the ‘big picture’ always informs your commercial decisions
Our Ask-the-Analyst™ service that puts you in direct contact with our global analyst team

Relevant products

Datamonitor Healthcare: data analysis and insight

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

Prioritize market opportunities
Identify unmet needs
Make informed decisions

Pharmapremia: Benchmark better and optimize your drug development pipeline

Using a peer-reviewed methodology that provides robust, unbiased drug phase success rates and timeline metrics by treatment indication, Pharmapremia enables you to make strong, informed decisions about your drug development pipeline.

Key benefits:

Manage portfolio risks
Analyze success factors
Create meaningful benchmarks

In Vivo: strategic insights for life sciences decision-makers

In Vivo offers comprehensive coverage of the global medical industry’s competitive landscape.

Key benefits:

Cutting edge thought leadership
Expert analysis
Hear from news makers

In Vivo

In Vivo Personalised Medicine

18 Sep 2019

With more individualized treatments, such as cell and gene therapies, coming to market every day, In Vivo can keep you up to date on the diversity within clinical R&D, trials, the latest trends and the barriers that still exist within personalised medicine. We’ve pulled together a helpful infographic to summaries these changes.

Topic Personalized Medicine

View infographic
In Vivo

Personalised Medicine: Treating the individual patient

17 Sep 2019

With more individualized treatments, such as cell and gene therapies, coming to market every day, In Vivo can keep you up to date on the diversity within clinical R&D, trials, the latest trends and the barriers that still exist within personalised medicine. We’ve pulled together information covering the increasing focus of personalized medicine in clinical R&D and the future trends of precision medicine.

Topic Personalized Medicine

Single report
Datamonitor Healthcare

Reimbursement and Payer Management of Immune Checkpoint Inhibitors

03 Sep 2019

As immune checkpoint inhibitors continue to gain approvals in expanded patient populations, payers express concern surrounding the potential budget impact of the drug class. Considering the high costs of these treatments in comparison to standard chemotherapy, HTA and reimbursement agencies stress the requirement for solid survival data and highlight that price will be a major factor during negotiations

Topic Drug review

Single report
In Vivo

Six of the Greatest Therapeutic R&D Challenges

23 Aug 2019

Explore the six biggest therapeutic R&D challenges facing the industry today with a free infographic from In Vivo. This snapshot view of the major issues facing R&D is packed with data and insights about everything from drug resistance to diagnostics challenges.

Topic Drug development landscape

View infographic
In Vivo

In Vivo Content - Relied Upon by Senior Decision Makers

21 Aug 2019

There are many ways to market your brand and establish your business as a thought leader - but none of these methods compare to the distinct advantage gained through marketing with In Vivo and Informa Pharma Intelligence. The articles, news and interviews we feature are used daily by senior decision-makers to support their decisions, and to keep abreast of what their competitors are doing.

Topic Business strategies Medtech

Single report
Datamonitor Healthcare

NASH Disease Coverage Extract

16 Aug 2019

Datamonitor Healthcare recently surveyed 60 gastroenterologists in the US and five major EU markets after the approval of the first disease-specific therapies for the treatment of non-alcoholic steatohepatitis (NASH). The market for these treatments will exceed $21bn in 2027.

Topic Drug development landscape Diseases

Single report
In Vivo

MedTech Forum 2019: The Future Is Here But Industry Still Needs A Long-Term Vision

By Ashley Yeo 16 Aug 2019

In a world where national economies are beset by conflicting spending priorities, health care is oftentimes too low on the agenda, health care observers say. One of these is Boston Scientific senior vice-president Eric Thépaut, who understands the dilemmas, but says that health care will soon force its way up the priority list. He has advice for future-ready medtech innovators.

Topic Medtech Business strategies

View article
In Vivo

Could The Gut Cure Brain Disease?

By Melanie Senior 08 Aug 2019

Scientists now understand that there are multiple, bi-directional links between gut and brain. They are using this knowledge to develop new treatments for some of the most challenging chronic conditions, including Alzheimer’s disease, Parkinson’s disease and obesity.

Topic Diseases

View article
In Vivo

Meet the 2019 Titans of Pharma

31 Jul 2019

Get exclusive info on the leaders of the Pharma industry.The 2019 Titan of Pharma infographic is a snapshot of the industry’s top leaders and the businesses they oversee.

Topic Company analysis Strategy

View infographic
In Vivo

How To Negotiate With Public Payers: Five Lessons - And A Few Cautions - From The UK's New Pact On Drug Price And Access

By William Looney 30 Jul 2019

In today’s globalized market for medicines, national rules on pricing and access are abundantly shared and more transparent than opaque. In Vivo speaks to the UK branded industry’s negotiator for the latest five-year joint pricing pact with the government, Richard Torbett, who outlines, among other topics, five widely applicable precedents from the talks that can work in “getting to yes” – despite the fractious budgetary climate for health care evident in all major country markets.

Topic Brexit Policy and regulation

View article
Scrip, In Vivo

AI in the Pharmaceutical Landscape

25 Jul 2019

AstraZeneca’s pact with the UK-based artificial intelligence leader BenevolentAI, in April 2019, is one component in a string of recent deals that have highlighted big pharma’s desire to embed AI and machine learning within the R&D process. In total, 13 such collaborations have been tracked in the past 24 months, according to the Strategic Transactions database.

Topic Digital Health Strategy Medtech

Single report
Datamonitor Healthcare

Top 10 Best Selling Drugs of 2018 Fund US and EU Pharma RD

15 Jul 2019

Our latest whitepaper lists the top selling drugs last year, who developed them and the strategies behind their success. We drew from three of our top products to create our most recent whitepaper, Datamonitor Health Care, Biomedtracker and Pharmaprojects. You can experience them all for yourself.

Topic Drug review Strategy Deal trends

View white paper
Datamonitor Healthcare, Biomedtracker, Pharmapremia

2019 Q3 Outlook Webinar

By Hardik Patel 15 Jul 2019

Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019.

Topic immuno-oncology Infectious diseases

Full video
In Vivo

MedTech Forum 2019: In The Medtech Glasshouse, Industry Need Not Fear Stones

By Ashley Yeo 12 Jul 2019

Medtech’s contribution to health care improvements in Europe over the past 30 years has been a phenomenal journey of success – in patient terms as well as in commercial terms, says MedTech Europe chair Rob ten Hoedt. Local creativity has been able to mine a seam of product innovation that is unmatched anywhere in the world, but the sector is facing massive change and must find ways to cope.

Topic Medtech Digital Health

View article
In Vivo

New Science As A Business Growth Strategy

By Sanskriti Thakur and Gordon Murphy 04 Jul 2019

Finding innovative ways to adapt the biopharma business model to external and internal challenges is a key competitive differentiator for today’s C-suite leadership.

Topic BioPharmaceutical Research

View article

Latest headlines

In Vivo

20 Sep 2019

C-Suite Snippets: A Fresh View From Old Science

Link
In Vivo

19 Sep 2019

In Vivo’s Quick Guide To Gene Therapy

Link
In Vivo

18 Sep 2019

Execs On The Move, September 2019

Link
In Vivo

11 Sep 2019

One For All Not All For One With Personalized Therapies

Link
In Vivo

11 Sep 2019

Fully-Connected Data Infrastructure Offering Will Support Individualized Cancer Therapies

Link
In Vivo

06 Sep 2019

C-Suite Snippets: Genomic Medicine Is Coming Of Age

Link
In Vivo

04 Sep 2019

Going Back To The Future To Treat Diabetes

Link
In Vivo

04 Sep 2019

Hidden Dagger In Diabetes: Heart Failure

Link
In Vivo

04 Sep 2019

Deals In Depth: July 2019

Link
In Vivo

02 Sep 2019

Illumina CSO Bentley Paints A Vision For The Future Of Precision Medicine

Link
In Vivo

27 Aug 2019

Science Matters: With Ferroptosis, Cancer Drug Developers Can Strike While Iron Is Hot

Link
In Vivo

21 Aug 2019

2018 Completed Clinical Trials: Change Is The New Constant

Link
In Vivo

19 Aug 2019

European Companies Are Now Being ‘Properly Funded’

Link
In Vivo

16 Aug 2019

C-Suite Snippets: Planning For The Future Cancer Market

Link
In Vivo

14 Aug 2019

Execs On The Move, August 2019

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Optimize your pharmaceutical portfolio strategy

​Drive commercial success

Relevant products

Below are the Product List

Datamonitor Healthcare: data analysis and insight

Pharmapremia: Benchmark better and optimize your drug development pipeline

In Vivo: strategic insights for life sciences decision-makers

Pharma Intelligence latest insights

Latest headlines

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store

Drive commercial success